A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible results WALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Applied Biosystems™ PowerFlex™ Thermal Cycler, a next-generation polymerase chain reaction (PCR) instrument designed to help deliver enhanced flexibility, […]

SAN DIEGO and NEW YORK — SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health System, one of the leading academic health systems in the United States, will adopt the AI-powered SOPHiA DDM™ Platform to advance cancer research and enhance genomic testing capabilities. Mount Sinai, a National […]

Former Bio-Rad EVP & CFO brings deep sector, financial, and governance experience to support Araceli’s next phase of growth  PORTLAND, Ore. — Araceli Biosciences today announced the appointment of Christine A. Tsingos to its Board of Directors, adding a seasoned public company executive with extensive experience in financial leadership, governance, and strategic growth.  Tsingos brings more than 30 years […]

ESPOO, Finland — New Finnish deep-tech company aims to make ultra-early disease detection possible through single-molecule protein amplification, enabling the identification of molecular warning signals long before disease becomes clinically visible. The technology has the potential to shift healthcare from reactive treatment to true prevention, extend healthy lifespans, and reduce the global burden of cancer, neurological disorders, and […]

New program matches top researchers with expert service providers trained to offer a comprehensive suite of Shasta® single-cell and bulk RNA-seq NGS solutions SAN JOSE, Calif. — Takara Bio USA, Inc. (“Takara Bio USA”), a wholly owned subsidiary of Takara Bio Inc. (“Takara Bio”), today announced the launch of the Takara Bio Certified Service Provider […]

Advancing discovery from lab to life through AI-driven insights, imaging, and end-to-end workflows WALTHAM, Mass. — Revvity, Inc. is showcasing its latest innovations in cancer research at the AACR Annual Meeting 2026, to be held in San Diego, April 17-22. The Company’s comprehensive suite of research use only (RUO) oncology solutions are designed to elevate preclinical and translational […]

Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands: R&D Systems™, Bio-Techne Spatial™, and Bio-Techne Diagnostics™. The new brand structure reflects the scientific journey, connecting early discoveries to translational insight to clinical decision-making. The portfolio brands will debut at the AACR Annual Meeting 2026 and AAI’s IMMUNOLOGY 2026™. MINNEAPOLIS — […]

Fremont, Calif. – Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, today announced the pricing of its upsized initial public offering of 11,250,000 shares of its common stock at a public offering price of $17.00 per share. In addition, Alamar has granted the underwriters a 30-day option […]

The PrepQuant™ system automates nucleic acid extraction, concentration, and quantification processes into a single sample preparation run contributing to improving the accuracy, reproducibility, and quality of genomic research PrepQuant™, an integrated nucleic acid extraction system with built-in quantification Tokyo – Hitachi High-Tech Corporation (“Hitachi High-Tech”) has jointly developed the PrepQuant™ system (“the system”), an integrated […]

Recently, Geneus Technologies, a leading domestic company in nanopore sequencing technology, announced the completion of a nearly RMB 100 million B++ round of financing. This round of funding was led by CDBT Group, with participation from Si Chuan Venture Capital. The raised capital will be used to accelerate the commercialization of the world’s first “Single-base […]